New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
This article was originally published in The Tan Sheet
You may also be interested in...
Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
Consumers Challenge DMAA Safety After DOD Bans Products
Complaints against GNC Holdings Inc., manufacturer Cellucor Sports Nutrition and Woodbolt Distribution and against USPLabs rely on DOD’s decision to ban sales of the product at military exchanges and moves by Canadian regulators to support their arguments.